Skip to main content
Top
Published in: Sleep and Breathing 3/2022

12-08-2021 | Sleep Apnea | Basic Science • Original Article

Densely granulated adenoma pattern is associated with an increased risk of obstructive sleep apnea in patients with acromegaly

Authors: Xianchao Zhao, Lijun Heng, Yan Qu, Dong Jia, Jiafeng Ren, Shuyu Sun, Jian Qiu, Jinxiang Cheng, Ting Yang, Junying Zhou, Changjun Su

Published in: Sleep and Breathing | Issue 3/2022

Login to get access

Abstract

Objectives

To explore the prevalence of obstructive sleep apnea (OSA) and the association between the adenoma granulation patterns and OSA in patients with acromegaly.

Methods

An overnight polysomnography (PSG) assessment was carried out on participants with acromegaly. Results classified participants into a non-OSA group, mild to moderate OSA group, and severe OSA group. Morphological and biochemical analyses were performed. Demographic, clinical, biochemical, and polysomnographic data were compared among the three groups. Using logistic regression models, the risk of OSA in acromegalic subjects was estimated.

Results

OSA was reported in 36 of 49 patients (74%) with acromegaly. Contrasted with the non-OSA group, OSA patients had a larger proportion of the densely granulated (DG) pattern. The OSA groups with DG acromegaly had a smaller maximum tumor diameter and Vol/2 than those with the sparsely granulated (SG) pattern. Furthermore, a higher growth hormone (GH) level (45.0 ± 36.9 vs 18.6 ± 15.8, P = 0.047) and GH index (28.4 ± 13.8 vs 6.6 ± 8.2, P = 0.003) were found in DG acromegaly patients with severe OSA. Additionally, there was a trend toward higher standardized insulin-like growth factor 1 (IGF-1) in patients with DG acromegaly than in those with SG acromegaly in the severe OSA group. After adjusting for potential confounding variables, the DG pattern was correlated with the risk of OSA (OR = 14.84, 95%CI 1.36–162.20, P = 0.027) in patients with acromegaly.

Conclusions

The findings indicate that a high prevalence of OSA exists in patients with acromegaly, and the DG pattern may be a risk factor for OSA in acromegaly.
Literature
3.
go back to reference Guo X et al (2018) Characteristics of the upper respiratory tract in patients with acromegaly and correlations with obstructive sleep apnoea/hypopnea syndrome. Sleep Med 48:27–34PubMedCrossRef Guo X et al (2018) Characteristics of the upper respiratory tract in patients with acromegaly and correlations with obstructive sleep apnoea/hypopnea syndrome. Sleep Med 48:27–34PubMedCrossRef
4.
go back to reference Rodrigues MP et al (2008) Craniofacial abnormalities, obesity, and hormonal alterations have similar effects in magnitude on the development of nocturnal hypoxemia in patients with acromegaly. J Endocrinol Invest 31(12):1052–1057PubMedCrossRef Rodrigues MP et al (2008) Craniofacial abnormalities, obesity, and hormonal alterations have similar effects in magnitude on the development of nocturnal hypoxemia in patients with acromegaly. J Endocrinol Invest 31(12):1052–1057PubMedCrossRef
5.
go back to reference Kashine S et al (2012) Characteristics of sleep-disordered breathing in Japanese patients with acromegaly. Endocr J 59(1):31–38PubMedCrossRef Kashine S et al (2012) Characteristics of sleep-disordered breathing in Japanese patients with acromegaly. Endocr J 59(1):31–38PubMedCrossRef
6.
go back to reference Kaw R et al (2012) Postoperative complications in patients with obstructive sleep apnea. Chest 141(2):436–441PubMedCrossRef Kaw R et al (2012) Postoperative complications in patients with obstructive sleep apnea. Chest 141(2):436–441PubMedCrossRef
7.
go back to reference Apnea ASOA (2014) Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 120(2):268–286CrossRef Apnea ASOA (2014) Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 120(2):268–286CrossRef
8.
go back to reference Franklin KA, Lindberg E (2015) Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis 7(8):1311–1322PubMedPubMedCentral Franklin KA, Lindberg E (2015) Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis 7(8):1311–1322PubMedPubMedCentral
9.
go back to reference Vannucci L et al (2013) Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. J Endocrinol Invest 36(4):237–242PubMed Vannucci L et al (2013) Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. J Endocrinol Invest 36(4):237–242PubMed
10.
go back to reference Castellani C et al (2016) Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients. Endocrine 51(2):308–316PubMedCrossRef Castellani C et al (2016) Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients. Endocrine 51(2):308–316PubMedCrossRef
11.
go back to reference Davi MV, Giustina A (2012) Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment. Expert Rev Endocrinol Metab 7(1):55–62PubMedCrossRef Davi MV, Giustina A (2012) Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment. Expert Rev Endocrinol Metab 7(1):55–62PubMedCrossRef
12.
go back to reference Wagenmakers MA et al (2015) Three-dimensional facial analysis in acromegaly: a novel tool to quantify craniofacial characteristics after long-term remission. Pituitary 18(1):126–134PubMedCrossRef Wagenmakers MA et al (2015) Three-dimensional facial analysis in acromegaly: a novel tool to quantify craniofacial characteristics after long-term remission. Pituitary 18(1):126–134PubMedCrossRef
13.
go back to reference Wolters TLC et al (2020) The course of obstructive sleep apnea syndrome in patients with acromegaly during treatment. J Clin Endocrinol Metab 105(1):290–304CrossRef Wolters TLC et al (2020) The course of obstructive sleep apnea syndrome in patients with acromegaly during treatment. J Clin Endocrinol Metab 105(1):290–304CrossRef
15.
go back to reference Kiseljak-Vassiliades K et al (2015) Growth hormone tumor histological subtypes predict response to surgical and medical therapy. Endocrine 49(1):231–241PubMedCrossRef Kiseljak-Vassiliades K et al (2015) Growth hormone tumor histological subtypes predict response to surgical and medical therapy. Endocrine 49(1):231–241PubMedCrossRef
16.
go back to reference Bakhtiar Y et al (2010) Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae. Eur J Endocrinol 163(4):531–539PubMedCrossRef Bakhtiar Y et al (2010) Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae. Eur J Endocrinol 163(4):531–539PubMedCrossRef
17.
go back to reference Fougner SL et al (2012) Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol 76(1):96–102CrossRef Fougner SL et al (2012) Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol 76(1):96–102CrossRef
18.
go back to reference Roemmler J et al (2012) Elevated incidence of sleep apnoea in acromegaly—correlation to disease activity. Sleep Breath 16(4):1247–1253PubMedCrossRef Roemmler J et al (2012) Elevated incidence of sleep apnoea in acromegaly—correlation to disease activity. Sleep Breath 16(4):1247–1253PubMedCrossRef
19.
go back to reference Guo X et al (2018) The posterior pharyngeal wall thickness is associated with OSAHS in patients with acromegaly and correlates with IGF-1 levels. Endocrine 61(3):526–532PubMedCrossRef Guo X et al (2018) The posterior pharyngeal wall thickness is associated with OSAHS in patients with acromegaly and correlates with IGF-1 levels. Endocrine 61(3):526–532PubMedCrossRef
20.
go back to reference Parolin M et al (2020) Obstructive sleep apnea in acromegaly and the effect of treatment: a systematic review and meta-analysis. J Clin Endocrinol Metab 105(3):dgz116PubMedCrossRef Parolin M et al (2020) Obstructive sleep apnea in acromegaly and the effect of treatment: a systematic review and meta-analysis. J Clin Endocrinol Metab 105(3):dgz116PubMedCrossRef
21.
go back to reference Katznelson L et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951PubMedCrossRef Katznelson L et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951PubMedCrossRef
23.
24.
go back to reference Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14(6):540–545PubMedCrossRef Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14(6):540–545PubMedCrossRef
25.
go back to reference Berry R, Rita B, Charlene G (2017) AASM scoring manual updates for 2017 (Version 2.4). J Clin Sleep Med 5(13):665–666CrossRef Berry R, Rita B, Charlene G (2017) AASM scoring manual updates for 2017 (Version 2.4). J Clin Sleep Med 5(13):665–666CrossRef
26.
go back to reference Annamalai AK et al (2013) A Comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab 98(3):1040–1050PubMedCrossRef Annamalai AK et al (2013) A Comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab 98(3):1040–1050PubMedCrossRef
27.
go back to reference Tsoy UA et al (2015) Clinical features of sleep-related breathing disorders in patients with acromegaly. Ter Arkh 87(4):47PubMedCrossRef Tsoy UA et al (2015) Clinical features of sleep-related breathing disorders in patients with acromegaly. Ter Arkh 87(4):47PubMedCrossRef
28.
go back to reference Senaratna CV et al (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81PubMedCrossRef Senaratna CV et al (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81PubMedCrossRef
30.
go back to reference Turan O et al (2018) Airway and sleep disorders in patients with acromegaly. Clin Respir J 12(3):1003–1010PubMedCrossRef Turan O et al (2018) Airway and sleep disorders in patients with acromegaly. Clin Respir J 12(3):1003–1010PubMedCrossRef
31.
go back to reference Pivonello R et al (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20(1):46–62PubMedCrossRef Pivonello R et al (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20(1):46–62PubMedCrossRef
32.
go back to reference Davi’ MV et al (2008) Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol 159(5):533–540PubMedCrossRef Davi’ MV et al (2008) Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol 159(5):533–540PubMedCrossRef
33.
go back to reference Bruwier A et al (2011) Acromegaly and sleep apnea: Cephalometric evaluations. Ann Endocrinol 72(3):211–217CrossRef Bruwier A et al (2011) Acromegaly and sleep apnea: Cephalometric evaluations. Ann Endocrinol 72(3):211–217CrossRef
34.
go back to reference Chennaoui M, Leger D, Gomez-Merino D (2020) Sleep and the GH/IGF-1 axis: consequences and countermeasures of sleep loss/disorders. Sleep Med Rev 49:101223PubMedCrossRef Chennaoui M, Leger D, Gomez-Merino D (2020) Sleep and the GH/IGF-1 axis: consequences and countermeasures of sleep loss/disorders. Sleep Med Rev 49:101223PubMedCrossRef
35.
go back to reference Weiss V et al (2000) Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 23(8):515–519PubMedCrossRef Weiss V et al (2000) Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 23(8):515–519PubMedCrossRef
36.
37.
go back to reference Hochban W et al (1999) Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur Respir J 14(1):196PubMedCrossRef Hochban W et al (1999) Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur Respir J 14(1):196PubMedCrossRef
38.
go back to reference Cadieux RJ et al (1982) Endoscopic findings in sleep apnea associated with acromegaly. J Clin Endocrinol Metab 55(1):18–22PubMedCrossRef Cadieux RJ et al (1982) Endoscopic findings in sleep apnea associated with acromegaly. J Clin Endocrinol Metab 55(1):18–22PubMedCrossRef
39.
go back to reference Akkoyunlu ME et al (2013) Does hormonal control obviate positive airway pressure therapy in acromegaly with sleep-disordered breathing? Respir Med 107(11):1803–1809PubMedCrossRef Akkoyunlu ME et al (2013) Does hormonal control obviate positive airway pressure therapy in acromegaly with sleep-disordered breathing? Respir Med 107(11):1803–1809PubMedCrossRef
40.
go back to reference Wennberg A et al (2019) Sleep disorders and cognitive dysfunction in acromegaly. Endocrine 66(3):634–641PubMedCrossRef Wennberg A et al (2019) Sleep disorders and cognitive dysfunction in acromegaly. Endocrine 66(3):634–641PubMedCrossRef
41.
go back to reference Choi E et al (2016) The severity of sleep disordered breathing induces different decrease in the oxygen saturation during rapid eye movement and non-rapid eye movement sleep. Psychiatry Investig 13(6):652PubMedPubMedCentralCrossRef Choi E et al (2016) The severity of sleep disordered breathing induces different decrease in the oxygen saturation during rapid eye movement and non-rapid eye movement sleep. Psychiatry Investig 13(6):652PubMedPubMedCentralCrossRef
42.
go back to reference Sharma SK et al (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8(1):12–17PubMedCrossRef Sharma SK et al (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8(1):12–17PubMedCrossRef
43.
go back to reference Leistner SM et al (2015) Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomas. Eur J Endocrinol 172(6):733–743PubMedCrossRef Leistner SM et al (2015) Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomas. Eur J Endocrinol 172(6):733–743PubMedCrossRef
Metadata
Title
Densely granulated adenoma pattern is associated with an increased risk of obstructive sleep apnea in patients with acromegaly
Authors
Xianchao Zhao
Lijun Heng
Yan Qu
Dong Jia
Jiafeng Ren
Shuyu Sun
Jian Qiu
Jinxiang Cheng
Ting Yang
Junying Zhou
Changjun Su
Publication date
12-08-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 3/2022
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-021-02468-z

Other articles of this Issue 3/2022

Sleep and Breathing 3/2022 Go to the issue